Filing Details
- Accession Number:
- 0001209191-17-046024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 19:58:50
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 19:58:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-19 | 25,500 | $96.87 | 156,967 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 38,250 | $109.14 | 195,217 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 14,875 | $131.89 | 210,092 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 10,775 | $91.05 | 220,867 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-19 | 60,400 | $161.00 | 160,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-19 | 29,000 | $162.67 | 131,467 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-21 | 2,125 | $131.89 | 133,592 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-21 | 2,125 | $159.00 | 131,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 10,150 | $161.68 | 121,317 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 200 | $161.72 | 121,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 25,500 | $0.00 | 25,500 | $96.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 38,250 | $0.00 | 38,250 | $109.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 14,875 | $0.00 | 14,875 | $131.89 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 10,775 | $0.00 | 10,775 | $91.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-21 | 2,125 | $0.00 | 2,125 | $131.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,500 | 2024-07-14 | No | 4 | M | Direct | |
| 38,250 | 2025-02-02 | No | 4 | M | Direct | |
| 19,125 | 2025-07-20 | No | 4 | M | Direct | |
| 23,707 | 2026-02-01 | No | 4 | M | Direct | |
| 17,000 | 2025-07-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 140 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 07/15/2014.
- The option vests in 16 quarterly installments from 02/03/2015.
- The option vests in 16 quarterly installments from 07/21/2015.
- The option vests in 16 quarterly installments from 02/02/2016.
Billionaire Hedge Funds
